- QMRO Home
- Blizard Institute
- Centre for Neuroscience, Surgery and Trauma
- Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study biomarker outcome results
Browse
Administrators only